Korean J Radiol.  2005 Sep;6(3):134-135. 10.3348/kjr.2005.6.3.134.

Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization: Difficulties on Imaging Follow-up

• Yu JS

• KMID: 1102708
• DOI: http://doi.org/10.3348/kjr.2005.6.3.134

Abstract

No abstract available.

MeSH Terms

Tomography, X-Ray Computed
Liver Neoplasms/*radiography/*therapy
Humans
*Chemoembolization, Therapeutic/methods
Carcinoma, Hepatocellular/radiography/*therapy

Reference

1. Lee JK, Chung YH, Song BC, Shin JW, Choi WB, Yang SH, et al. Recurrences of hepatcellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol. 2002. 17:52–58.

2. Choi BI, Kim HC, Han JK, Park JH, Kim YI, Kim ST, et al. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology. 1992. 182:709–713.

3. Takayasu K, Arii S, Matsuo N, Yoshikawa M, Ryu M, Takasaki K, et al. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol. 2000. 175:699–704.

4. Kim HC, Kim AY, Han JK, Chung JW, Lee JY, Park JH, et al. Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images. Radiology. 2002. 225:773–780.

5. Jang KM, Choi D, Lim HK, Lim JH, Lee JY, Lee WJ, et al. Depiction of viable tumor in hepatocellular carcinoma treated with transarterial chemoembolization: multiphasic helical CT with review of previous serial CT images. Korean J Radiol. 2005. 6:153–160.

6. Imaeda T, Yamawaki Y, Seki M, Goto H, Iinuma G, Kanematsu M, et al. Lipiodol retention and massive necrosis after Lipiodol-chemoembolization of hepatocellular carcinoma; correlation between computed tomography and histopathology. Cardiovasc Intervent Radiol. 1993. 16:209–221.

7. Kubota K, Hisa N, Nishikawa T, Fujiwara Y, Murata Y, Itoh S, et al. Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging. 2001. 26:184–190.

8. De Santis M, Alborino S, Tartoni PL, Torricelli P, Casolo A, Romagnoli R. Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization. Eur Radiol. 1997. 7:10–16.

9. Yu JS, Kim KW, Sung KB, Lee JT, Yoo HS. Small arterial-portal venous shunts: a cause of pseudolesions at hepatic imaging. Radiology. 1997. 203:737–742.

10. Mori K, Yoshioka H, Itai Y, Okamoto Y, Mori H, Takahashi N, et al. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. AJR Am J Roentgenol. 2000. 175:1659–1664.

11. Yu JS, Kim KW, Park MS, Yoon SW. Bile duct injuries leading to portal vein obliteration after transcatheter arterial chemoembolization in the liver: CT findings and initial observations. Radiology. 2001. 221:429–436.

12. Yu JS, Kim KW, Jeong MG, Lee DH, Park MS, Yoon SW. Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. Cardiovasc Intervent Radiol. 2002. 25:270–274.